OPKO Health (OPK) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barrington Research | Downgraded | Outperform → Market Perform | — | Apr 29, 2026 |
| Barrington Research | Maintained | Outperform | $1.50 from $2.25 | Mar 2, 2026 |
| JP Morgan | Initiated Coverage | Neutral | — | Nov 20, 2025 |
| Jefferies | Downgraded | Buy → Hold | $1.60 from $2.00 | Oct 31, 2025 |
| Barrington Research | Maintained | Outperform | $2.25 | Oct 30, 2025 |
| Barrington Research | Maintained | Outperform | $2.25 | May 1, 2025 |
| JP Morgan | Initiated Coverage | Neutral | — | Apr 25, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Apr 7, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Mar 19, 2025 |
| Barrington Research | Maintained | Outperform | $2.25 | Mar 12, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Mar 12, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Mar 3, 2025 |
| Barrington Research | Maintained | Outperform | $2.25 | Feb 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Jan 8, 2025 |
| Barrington Research | Maintained | Outperform | $2.25 | Nov 8, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Sep 26, 2024 |
| Barrington Research | Maintained | Outperform | $2.25 | Sep 20, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Sep 17, 2024 |
| Piper Sandler | Maintained | Overweight | $3.00 | Sep 17, 2024 |
| Barrington Research | Maintained | Outperform | $2.25 from $1.50 | Aug 8, 2024 |
Frequently asked questions
Is OPK a buy, sell, or hold?
Analysts covering OPKO Health currently average a Buy rating: 4 buy, 2 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on OPK?
On Apr 29, 2026, Barrington Research downgraded OPKO Health to Market Perform.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.